Cosmotec Medicaments Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 03-07-2024
- Paid Up Capital ₹ 8.89 M
as on 03-07-2024
- Company Age 23 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.57 M
as on 03-07-2024
- Satisfied Charges ₹ 4.50 M
as on 03-07-2024
- Revenue -62.66%
(FY 2023)
- Profit -9.80%
(FY 2023)
- Ebitda -230.88%
(FY 2023)
- Net Worth 0.88%
(FY 2023)
- Total Assets -33.43%
(FY 2023)
About Cosmotec Medicaments
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 8.89 M.
The company currently has active open charges totaling ₹7.57 M. The company has closed loans amounting to ₹4.50 M, as per Ministry of Corporate Affairs (MCA) records.
Alka Goyal, Jitender Kumar, and Rajesh Goyal serve as directors at the Company.
- CIN/LLPIN
U51397DL2001PTC111620
- Company No.
111620
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2001
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Cosmotec Medicaments Private Limited offer?
Cosmotec Medicaments Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Vacuum Therapy & Laser Therapy Equipments, Tissue Unifying Instruments & Materials, Aneurysm Clip, Forceps & Graspers, Surgical Knives, Compressible Limb Therapy System, Surgical Accessories, Skin Graft Mesher, Graspers.
Who are the key members and board of directors at Cosmotec Medicaments?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alka Goyal  | Director | 11-Jul-2001 | Current |
| Jitender Kumar | Director | 11-Jul-2001 | Current |
| Rajesh Goyal | Director | 30-Jul-2001 | Current |
Financial Performance of Cosmotec Medicaments.
Cosmotec Medicaments Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 62.66% decrease. The company also saw a slight decrease in profitability, with a 9.8% decrease in profit. The company's net worth moved up by a moderate rise of 0.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosmotec Medicaments?
In 2023, Cosmotec Medicaments had a promoter holding of 35.67% and a public holding of 64.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Feb 2013 | ₹3.07 M | Open |
3I Infotech Trusteeship Services Limited Creation Date: 28 Jan 2010 | ₹4.50 M | Open |
3I Infotech Trusteeship Services Limited Creation Date: 16 Jan 2010 | ₹4.50 M | Satisfied |
How Many Employees Work at Cosmotec Medicaments?
Unlock and access historical data on people associated with Cosmotec Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmotec Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmotec Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
